{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T02:52:33Z","timestamp":1771901553717,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,30]]},"DOI":"10.7759\/cureus.20839","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T23:46:56Z","timestamp":1640908016000},"source":"Crossref","is-referenced-by-count":3,"title":["Minoxidil, Platelet-Rich Plasma (PRP), or Combined Minoxidil and PRP for Androgenetic Alopecia in Men: A Cost-Effectiveness Markov Decision Analysis of Prospective Studies"],"prefix":"10.7759","author":[{"given":"Kevin M","family":"Klifto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sammy","family":"Othman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J","family":"Kovach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14624","article-title":"Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version","volume":"32","author":"Kanti V","year":"2018","unstructured":"Kanti V, Messenger A, Dobos G, et al.. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. J Eur Acad Dermatol Venereol. 2018, 32:11-22. 10.1111\/jdv.14624","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamafacial.2018.1052","article-title":"Association of hair loss with health utility measurements before and after hair transplant surgery in men and women","volume":"20","author":"Abt NB","year":"2018","unstructured":"Abt NB, Quatela O, Heiser A, Jowett N, Tessler O, Lee LN. Association of hair loss with health utility measurements before and after hair transplant surgery in men and women. JAMA Facial Plast Surg. 2018, 20:495-500. 10.1001\/jamafacial.2018.1052","journal-title":"JAMA Facial Plast Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.1394","article-title":"Association between gender and drug cost for over-the-counter minoxidil","volume":"153","author":"Wehner MR","year":"2017","unstructured":"Wehner MR, Nead KT, Lipoff JB. Association between gender and drug cost for over-the-counter minoxidil. JAMA Dermatol. 2017, 153:825-6. 10.1001\/jamadermatol.2017.1394","journal-title":"JAMA Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14143","article-title":"Platelet-rich plasma for androgenetic alopecia: efficacy differences between men and women","volume":"33","author":"Gupta AK","year":"2020","unstructured":"Gupta AK, Renaud HJ, Bamimore M. Platelet-rich plasma for androgenetic alopecia: efficacy differences between men and women. Dermatol Ther. 2020, 33:e14143. 10.1111\/dth.14143","journal-title":"Dermatol Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.101B8.BJJ-2019-0037.R1","article-title":"Classification systems for platelet-rich plasma","volume":"101-B","author":"Rossi LA","year":"2019","unstructured":"Rossi LA, Murray IR, Chu CR, Muschler GF, Rodeo SA, Piuzzi NS. Classification systems for platelet-rich plasma. Bone Joint J. 2019, 101-B:891-6. 10.1302\/0301-620X.101B8.BJJ-2019-0037.R1","journal-title":"Bone Joint J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines7020027","article-title":"Platelet-rich plasma and micrografts enriched with autologous human follicle mesenchymal stem cells improve hair re-growth in androgenetic alopecia. Biomolecular pathway analysis and clinical evaluation","volume":"7","author":"Gentile P","year":"2019","unstructured":"Gentile P, Scioli MG, Bielli A, et al.. Platelet-rich plasma and micrografts enriched with autologous human follicle mesenchymal stem cells improve hair re-growth in androgenetic alopecia. Biomolecular pathway analysis and clinical evaluation. Biomedicines. 2019, 7:27. 10.3390\/biomedicines7020027","journal-title":"Biomedicines"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050466","article-title":"Advances in regenerative stem cell therapy in androgenic alopecia and hair loss: wnt pathway, growth-factor, and mesenchymal stem cell signaling impact analysis on cell growth and hair follicle development","volume":"8","author":"Gentile P","year":"2019","unstructured":"Gentile P, Garcovich S. Advances in regenerative stem cell therapy in androgenic alopecia and hair loss: wnt pathway, growth-factor, and mesenchymal stem cell signaling impact analysis on cell growth and hair follicle development. Cells. 2019, 8:466. 10.3390\/cells8050466","journal-title":"Cells"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/760709","article-title":"The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation","volume":"2014","author":"Cervelli V","year":"2014","unstructured":"Cervelli V, Garcovich S, Bielli A, et al.. The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation. Biomed Res Int. 2014, 2014:760709. 10.1155\/2014\/760709","journal-title":"Biomed Res Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9554.1000447","article-title":"Autologous adipose derived stem cell versus platelet rich plasma injection in the treatment of androgenetic alopecia: efficacy, side effects and safety","volume":"9","author":"Kadry MH","year":"2018","unstructured":"Kadry MH, El-Kheir WA, Shalaby ME, El Shahid AR, Metwally HG. Autologous adipose derived stem cell versus platelet rich plasma injection in the treatment of androgenetic alopecia: efficacy, side effects and safety. J Clin Exp Dermatol Res. 2018, 9:1000447. 10.4172\/2155-9554.1000447","journal-title":"J Clin Exp Dermatol Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/ijt.ijt_75_16","article-title":"A comparative study of microneedling with platelet-rich plasma plus topical minoxidil (5%) and topical minoxidil (5%) alone in androgenetic alopecia","volume":"9","author":"Shah KB","year":"2017","unstructured":"Shah KB, Shah AN, Solanki RB, Raval RC. A comparative study of microneedling with platelet-rich plasma plus topical minoxidil (5%) and topical minoxidil (5%) alone in androgenetic alopecia. Int J Trichology. 2017, 9:14-8. 10.4103\/ijt.ijt_75_16","journal-title":"Int J Trichology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_589_18","article-title":"Comparison of efficacy of platelet-rich plasma therapy with or without topical 5% minoxidil in male-type baldness: a randomized, double-blind placebo control trial","volume":"86","author":"Singh SK","year":"2020","unstructured":"Singh SK, Kumar V, Rai T. Comparison of efficacy of platelet-rich plasma therapy with or without topical 5% minoxidil in male-type baldness: a randomized, double-blind placebo control trial. Indian J Dermatol Venereol Leprol. 2020, 86:150-7. 10.4103\/ijdvl.IJDVL_589_18","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12864","article-title":"Platelet-rich plasma and microneedling improves hair growth in patients of androgenetic alopecia when used as an adjuvant to minoxidil","volume":"18","author":"Jha AK","year":"2019","unstructured":"Jha AK, Vinay K, Zeeshan M, Roy PK, Chaudhary RK, Priya A. Platelet-rich plasma and microneedling improves hair growth in patients of androgenetic alopecia when used as an adjuvant to minoxidil. J Cosmet Dermatol. 2019, 18:1330-5. 10.1111\/jocd.12864","journal-title":"J Cosmet Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/ijt.ijt_64_18","article-title":"A study to compare the efficacy of platelet-rich plasma and minoxidil therapy for the treatment of androgenetic alopecia","volume":"11","author":"Verma K","year":"2019","unstructured":"Verma K, Tegta GR, Verma G, Gupta M, Negi A, Sharma R. A study to compare the efficacy of platelet-rich plasma and minoxidil therapy for the treatment of androgenetic alopecia. Int J Trichology. 2019, 11:68-79. 10.4103\/ijt.ijt_64_18","journal-title":"Int J Trichology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000375320","article-title":"A single-centre, randomized, double-blind, placebo-controlled clinical trial to investigate the efficacy and safety of minoxidil topical foam in frontotemporal and vertex androgenetic alopecia in men","volume":"28","author":"Hillmann K","year":"2015","unstructured":"Hillmann K, Garcia Bartels N, Kottner J, Stroux A, Canfield D, Blume-Peytavi U. A single-centre, randomized, double-blind, placebo-controlled clinical trial to investigate the efficacy and safety of minoxidil topical foam in frontotemporal and vertex androgenetic alopecia in men. Skin Pharmacol Physiol. 2015, 28:236-44. 10.1159\/000375320","journal-title":"Skin Pharmacol Physiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13146","article-title":"Platelet-rich plasma injections in the treatment of male androgenetic alopecia: a randomized placebo-controlled crossover study","volume":"19","author":"Dicle \u00d6","year":"2020","unstructured":"Dicle \u00d6, Bilgic Temel A, G\u00fclkesen KH. Platelet-rich plasma injections in the treatment of male androgenetic alopecia: a randomized placebo-controlled crossover study. J Cosmet Dermatol. 2020, 19:1071-7. 10.1111\/jocd.13146","journal-title":"J Cosmet Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/psb.1562","article-title":"QALYs and their role in the NICE decision-making process","volume":"28","author":"Ogden J","year":"2017","unstructured":"Ogden J. QALYs and their role in the NICE decision-making process. Prescriber. 2017, 28:41-3. 10.1002\/psb.1562","journal-title":"Prescriber"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders GD","year":"2016","unstructured":"Sanders GD, Neumann PJ, Basu A, et al.. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016, 316:1093-103. 10.1001\/jama.2016.12195","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann PJ","year":"2014","unstructured":"Neumann PJ, Cohen JT, Weinstein MC. Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold. N Engl J Med. 2014, 371:796-7. 10.1056\/NEJMp1405158","journal-title":"N Engl J Med"},{"key":"ref19","unstructured":"Centers for Disease Control and Prevention. About underlying cause of death, 1999-2020. (2020). Accessed. January 4, 2021: https:\/\/wonder.cdc.gov\/ucd-icd10.html."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200708050-00003","article-title":"Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial","volume":"8","author":"Shin HS","year":"2007","unstructured":"Shin HS, Won CH, Lee SH, Kwon OS, Kim KH, Eun HC. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial. Am J Clin Dermatol. 2007, 8:285-90. 10.2165\/00128071-200708050-00003","journal-title":"Am J Clin Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2009.00673.x","article-title":"Randomized clinical trial comparing 5% and 1% topical minoxidil for the treatment of androgenetic alopecia in Japanese men","volume":"36","author":"Tsuboi R","year":"2009","unstructured":"Tsuboi R, Arano O, Nishikawa T, Yamada H, Katsuoka K. Randomized clinical trial comparing 5% and 1% topical minoxidil for the treatment of androgenetic alopecia in Japanese men. J Dermatol. 2009, 36:437-46. 10.1111\/j.1346-8138.2009.00673.x","journal-title":"J Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7813","article-title":"Bayesian measurement-error-driven hidden Markov regression model for calibrating the effect of covariates on multistate outcomes: application to androgenetic alopecia","volume":"37","author":"Yen AM","year":"2018","unstructured":"Yen AM, Chen HH. Bayesian measurement-error-driven hidden Markov regression model for calibrating the effect of covariates on multistate outcomes: application to androgenetic alopecia. Stat Med. 2018, 37:3125-46. 10.1002\/sim.7813","journal-title":"Stat Med"},{"key":"ref23","unstructured":"Centers for Medicare & Medicaid Services. Physician fee schedule search. (2019). Accessed. January 3, 2021: https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/PFSlookup."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.19.01446","article-title":"The cost-effectiveness of platelet-rich plasma injections for knee osteoarthritis: a Markov decision analysis","volume":"102","author":"Rajan PV","year":"2020","unstructured":"Rajan PV, Ng MK, Klika A, Kamath AF, Muschler GF, Higuera CA, Piuzzi NS. The cost-effectiveness of platelet-rich plasma injections for knee osteoarthritis: a Markov decision analysis. J Bone Joint Surg Am. 2020, 102:e104. 10.2106\/JBJS.19.01446","journal-title":"J Bone Joint Surg Am"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.arthro.2015.12.018","article-title":"The cost-effectiveness of using platelet-rich plasma during rotator cuff repair: a Markov model analysis","volume":"32","author":"Samuelson EM","year":"2016","unstructured":"Samuelson EM, Odum SM, Fleischli JE. The cost-effectiveness of using platelet-rich plasma during rotator cuff repair: a Markov model analysis. Arthroscopy. 2016, 32:1237-44. 10.1016\/j.arthro.2015.12.018","journal-title":"Arthroscopy"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.arthro.2020.07.027","article-title":"The cost-effectiveness of platelet-rich plasma compared with hyaluronic acid injections for the treatment of knee osteoarthritis","volume":"36","author":"Samuelson EM","year":"2020","unstructured":"Samuelson EM, Ebel JA, Reynolds SB, Arnold RM, Brown DE. The cost-effectiveness of platelet-rich plasma compared with hyaluronic acid injections for the treatment of knee osteoarthritis. Arthroscopy. 2020, 36:3072-8. 10.1016\/j.arthro.2020.07.027","journal-title":"Arthroscopy"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.arthro.2020.02.004","article-title":"What is the appropriate price for platelet-rich plasma injections for knee osteoarthritis? A\u00a0cost-effectiveness analysis based on evidence from level I randomized controlled trials","volume":"36","author":"Bendich I","year":"2020","unstructured":"Bendich I, Rubenstein WJ, Cole BJ, Ma CB, Feeley BT, Lansdown DA. What is the appropriate price for platelet-rich plasma injections for knee osteoarthritis? A\u00a0cost-effectiveness analysis based on evidence from level I randomized controlled trials. Arthroscopy. 2020, 36:1983-91.e1. 10.1016\/j.arthro.2020.02.004","journal-title":"Arthroscopy"},{"key":"ref28","unstructured":"U.S. Census Bureau. Table P-37. full-time, year-round all workers by mean income and sex: 1955 to 2019. (2020). Accessed: January 3, 2021: https:\/\/www.census.gov\/data\/tables\/time-series\/demo\/income-poverty\/historical-income-people.html."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASW.0000323589.27605.71","article-title":"An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers","volume":"21","author":"Dougherty EJ","year":"2008","unstructured":"Dougherty EJ. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers. Adv Skin Wound Care. 2008, 21:568-75. 10.1097\/01.ASW.0000323589.27605.71","journal-title":"Adv Skin Wound Care"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/2325967119900811","article-title":"An analysis of current treatment trends in platelet-rich plasma therapy in the Medicare database","volume":"8","author":"Werner BC","year":"2020","unstructured":"Werner BC, Cancienne JM, Browning R, Verma NN, Cole BJ. An analysis of current treatment trends in platelet-rich plasma therapy in the Medicare database. Orthop J Sports Med. 2020, 8:2325967119900811. 10.1177\/2325967119900811","journal-title":"Orthop J Sports Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/79971-minoxidil-platelet-rich-plasma-prp-or-combined-minoxidil-and-prp-for-androgenetic-alopecia-in-men-a-cost-effectiveness-markov-decision-analysis-of-prospective-studies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:37Z","timestamp":1707507037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/79971-minoxidil-platelet-rich-plasma-prp-or-combined-minoxidil-and-prp-for-androgenetic-alopecia-in-men-a-cost-effectiveness-markov-decision-analysis-of-prospective-studies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,30]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.20839","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,30]]}}}